Xtandi

Is This Pfizer's Next Mega-Blockbuster Cancer Drug?
Is This Pfizer's Next Mega-Blockbuster Cancer Drug?
Motley Fool
Pfizer
Medivation
Xtandi
avelumab
Merck KGaA
Ibrance
Flag link:
Pfizer: Hospira Is Future; Xtandi Is Today's Meal
Pfizer: Hospira Is Future; Xtandi Is Today's Meal
Yahoo/GuruFocus
Pfizer
Hospira
Xtandi
M&A
Medivation
Flag link:
Key FDA Decisions and Trial Results Coming in the Next 2 Months
Key FDA Decisions and Trial Results Coming in the Next 2 Months
24/7 Wall St
FDA
clinical trials
Array Biopharma
binimetinib
Mast Therapeutics
Novavax
RSV F vaccine
Threshold Pharmaceuticals
tarloxotinib
Cerulean Pharma
Vertex Pharmaceuticals
Orkambi
Exelixis
cabozantinib
Cobimetinib
Medivation
Xtandi
Celldex
Flag link:
Key FDA Decisions and Trial Results Expected in October
Key FDA Decisions and Trial Results Expected in October
24/7 Wall St
FDA
clinical trials
cabozantinib
Cobimetinib
Exelixis
Medivation
Xtandi
Celldex Therapeutics
glemba
Palatin
bremelanotide
CRLX101
Cerulean Pharma
Anthera Pharmaceuticals
Flag link:
Ibrance and Xtandi Could Be in the Top 10 Oncology Drugs by 2021
Ibrance and Xtandi Could Be in the Top 10 Oncology Drugs by 2021
Market Realist
Ibrance
Xtandi
oncology
Pfizer
Medivation
breast cancer
prostate cancer
Flag link:
How Mylan And Pfizer Could Cause A Major Biotech Backlash
How Mylan And Pfizer Could Cause A Major Biotech Backlash
Forbes
Mylan Labs
Pfizer
EpiPen
Xtandi
Flag link:
What Pfizer Gets in Its $14 Billion Medivation Deal
What Pfizer Gets in Its $14 Billion Medivation Deal
Motley Fool
Pfizer
Medivation
M&A
Xtandi
prostate cancer
talazoparib
pidilizumab
Flag link:
Pfizer spent $14 billion on a company with just one approved drug — here's why that's a game changer
Pfizer spent $14 billion on a company with just one approved drug — here's why that's a game changer
Yahoo/Business Insider
Pfizer
Medivation
M&A
Sanofi
Xtandi
prostate cancer
pidilizumab
talazoparib
Flag link:
Pfizer agrees to buy cancer behemoth Medivation for $14 billion
Pfizer agrees to buy cancer behemoth Medivation for $14 billion
Marketwatch
Pfizer
M&A
Medivation
Sanofi
Xtandi
Flag link:
Xtandi's blockbuster Q2 growth shows why Big Pharma wants a Medivation deal
Xtandi's blockbuster Q2 growth shows why Big Pharma wants a Medivation deal
Fierce Pharma
Xtandi
Medivation
M&A
earnings
Flag link:
Medivation: Xtandi Global Sales Rose 53% in 1Q16
Medivation: Xtandi Global Sales Rose 53% in 1Q16
Yahoo/Market Realist
Medivation
Xtandi
Flag link:
Analyzing Medivation’s Growth Opportunity with Xtandi
Analyzing Medivation’s Growth Opportunity with Xtandi
Yahoo/Market Realist
Medivation
Xtandi
metastatic castration-resistant prostate cancer
prostate cancer
Flag link:
Here's What Medivation Said In Its Rejection Letter To Sanofi
Here's What Medivation Said In Its Rejection Letter To Sanofi
Yahoo/Benzinga
Medivation
Sanofi
M&A
Xtandi
Flag link:
Shifting prostate landscape underpins Sanofi’s Medivation offer
Shifting prostate landscape underpins Sanofi’s Medivation offer
EP Vantage
prostate cancer
Sanofi
Medivation
M&A
Xtandi
Flag link:
A frustrated Sanofi makes $9.3 billion bid for Medivation and its cancer drug
A frustrated Sanofi makes $9.3 billion bid for Medivation and its cancer drug
Stat
Sanofi
Medivation
M&A
Xtandi
Flag link:
Report: AstraZeneca considering bid for cancer biotech Medivation
Report: AstraZeneca considering bid for cancer biotech Medivation
BioPharma Dive
AstraZeneca
Medivation
Sanofi
M&A
Xtandi
Flag link:
Patent Palooza: One Patent Battle in Hep C, And Another Patent Brawl Brewing On Capitol Hill
Patent Palooza: One Patent Battle in Hep C, And Another Patent Brawl Brewing On Capitol Hill
Motley Fool
patents
hepatitis C
Medivation
Xtandi
Merck
Ionis Pharmaceuticals
Gilead Sciences
Flag link:
Congress just fired a shot against its next drug-pricing target, and its shares took a hit
Congress just fired a shot against its next drug-pricing target, and its shares took a hit
Yahoo/Business Insider
US Congress
drug pricing
Medivation
Astellas
Xtandi
Flag link:
Medivation's Xtandi sales force due for hiring, revamp as urology push falls flat
Medivation's Xtandi sales force due for hiring, revamp as urology push falls flat
Fierce Pharma Marketing
Medivation
Xtandi
hirings
Astellas
Flag link:
4 Blockbuster Drugs Whose Sales Could Easily Double
4 Blockbuster Drugs Whose Sales Could Easily Double
Motley Fool
Xtandi
Medivation
Astellas
Eliquis
Pfizer
Bristol-Myers Squibb
Revlimid
Celgene
Invokana
JNJ
Flag link: